New Delhi, April 30 (IANS) There is no proposal to introduce TB drug Bedaquiline in the Indian market, parliament was told Tuesday.
“No application under the Drugs and Cosmetic Rules has been received by the Drug Controller General (of India) for the grant of permission to market the drug,” Health Minister Ghulam Nabi Azad told the Rajya Sabha in reply to a question.
A new drug can only be introduced in the Indian market after due approval from the Drug Controller General of India (DCGI).
The prevalence of TB cases in the country is showing a declining trend. The estimated prevalence of TB has been brought down from 586 per lakh (1,00,000) population (1990) to 249 per lakh population in 2009, according to the WHO global report 2010.
The opinions, beliefs and viewpoints expressed by authors, news service providers on this page do not necessarily reflect the opinions, beliefs and viewpoints of Hill Post. Any views or opinions are not intended to malign any religion, ethnic group, club, organization, company, or individual.
Hill Post makes no representations as to the accuracy or completeness of any information on this site page.
